Skip to main content
Journal ArticleOPEN ACCESS

Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer

  • Kim J
  • Oh S
  • Kwon H
  • et al.
Cancer Research and Treatment (2008) 40(3) 101
DOI: 10.4143/crt.2008.40.3.101
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Metastatic breast cancer patients are usually exposed to taxane and anthracycline as neoadjuvant, adjuvant and palliative chemotherapeutic agents. This study was designed to determine the efficacy and safety of the use of a gemcitabine and cisplatin (GP) combination treatment in patients with metastatic breast cancer that were pretreated with anthracycline and taxane.

Cite

CITATION STYLE

APA

Kim, J. H., Oh, S. Y., Kwon, H.-C., Lee, S., Kim, S.-H., Kim, D.-C., … Kim, H.-J. (2008). Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer. Cancer Research and Treatment, 40(3), 101. https://doi.org/10.4143/crt.2008.40.3.101

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free